Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Staphylococcus aureus infection-driven myeloid-derived suppressor cells

ABSTRACT: Critical role of immune metabolism in Staphylococcus aureus infection-driven myeloid-derived suppressor cells and disease tolerance

PROVIDER: PRJEB37074 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR3978860.fastq.gz	Fastqsanger.gz
	ERR3978891.fastq.gz	Fastqsanger.gz
	ERR3979014.fastq.gz	Fastqsanger.gz
	ERR3975185.fastq.gz	Fastqsanger.gz
	ERR3978695.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 16

Similar Datasets

Immune metabolism regulates myeloid-derived suppressor cells expansion and disease tolerance in Staphylococcus aureus chronic infection

Project description:Critical role of immune metabolism in Staphylococcus aureus infection-driven myeloid-derived suppressor cells and disease tolerance

| PRJEB38066 | ENA

Myeloid-derived Suppressor Cells in Colorectal Cancer

Project description:The aim of the study is to evaluate whether the preoperative level of myeloid-derived suppressor cells is associated with postoperative complications classified by Clavien-Dindo categories. Levels of all MDSC, polymorphonuclear MDSC (PMNMDSC), monocytic MDSC (MMDSC), early-stage MDSC (EMDSC) and monocytic to polymorphonuclear MDSC ratio (M/PMN MDCS) were established and compared in patients with postoperative complications, severe postoperative complications (>= IIIA according to Clavien-Dindo) and severe septic complications.

| 2381881 | ecrin-mdr-crc

A fetal tumor suppressor axis abrogates MLL-fusion-driven acute myeloid leukemia

Project description:A fetal tumor suppressor axis abrogates MLL-fusion-driven acute myeloid leukemia

| PRJNA831190 | ENA

Early life microbiota exposure restricts myeloid-derived suppressor cell driven colonic tumorigenesis

Project description:Early life microbiota exposure restricts myeloid-derived suppressor cell driven colonic tumorigenesis

| PRJEB30607 | ENA

Early life microbiota exposure restricts myeloid-derived suppressor cell driven colonic tumorigenesis

Project description:Early life microbiota exposure restricts myeloid-derived suppressor cell driven colonic tumorigenesis

| PRJEB30606 | ENA

MDSC in Staphylococcus aureus infection

Project description:Role of immune metabolism in Staphylococcus aureus infection-driven myeloid-derived suppressor cells and disease tolerance

| PRJEB37303 | ENA

LKB1 is a suppressor of amino acid-driven gluconeogenesis in the liver

Project description:Excessive hepatic glucose production is a major contributor to the hyperglycemia observed in Type 2 diabetes mellitus. It is widely accepted that it is due to an increase in hepatic gluconeogenesis. While much attention has been devoted to the transcriptional regulation of key gluconeogenic enzymes, much less is known about the regulation of amino acid catabolism that provides gluconeogenic substrates. Here, we emphasize a novel role of LKB1 in this regulation. We show that mice with a hepatocyte-specific deletion of Lkb1 have increased hepatic amino acid catabolism for gluconeogenesis. This occurred during fasting, as well as during the postprandial period, identifying Lkb1 as a critical suppressor of hepatic postprandial gluconeogenesis. Hepatic Lkb1 deletion was also associated with severe alterations in whole body metabolism leading to decreased lean body mass deposition on MRI analysis and, at a longer term, cachexia and sarcopenia as a consequence of the diversion of amino acids for liver metabolism at the expense of muscle. Using genetic and pharmacological approaches, we identified the aminotransferases and Agxt and as critical effectors of the suppressor function of Lkb1 in amino acid-driven gluconeogenesis.

2020-12-01 | PXD013478 | Pride

Haplodeficiency of the 9p21 Tumor Suppressor Locus Causes Myeloid Disorders Driven by Bone Marrow Microenvironment

Project description:Haplodeficiency of the 9p21 Tumor Suppressor Locus Causes Myeloid Disorders Driven by Bone Marrow Microenvironment

| PRJNA872106 | ENA

RNASeq analysis of Myeloid Derived Suppressor Cells (MDSCs) from MC38 syngeneic mice to study their role on tumour intrinsic pathways (STING/IFN) for driving ceralasertib (AZD6738) efficacy

Project description:Understanding MoA of ceralasertib (AZD6738) in driving efficacy through immune regulation via polymorphonuclear-myeloid derived suppressor cells (PMN-MDSC) and monocytic-myeloid derived suppressor cells (M-MDSC) on tumour intrinsic pathways (STING/IFN) for AZD6738 driven efficacy. Animals were treated only for 7 days and left for further 7 days without treatment. We compared cells against Vehicle and spleen derived ( naive) as a positive control.

2024-01-30 | E-MTAB-13707 | biostudies-arrayexpress

Shariatpanahi2018 - Mathematical modeling of tumor-induced immunosuppression by myeloid-derived suppressor cells

Project description:This is a ODE-based mathematical model featuring equations describing the dynamics of tumor cells, cytotoxic T cells, natural killer cells, and myeloid-derived suppressor cells (MDSCs) that together describe the tumor-induced immunosuppression caused by MDSCs.

2019-09-09 | MODEL1909090003 | BioModels

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data